Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Announces Upcoming 2016 Investor Conference Presentation

02/02/16

TARRYTOWN, N.Y., Feb. 2, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast a management presentation at the following investor conference: Leerink Partners 5th Annual Global Healthcare Conference at 8:30 a.m. Eastern Time on Thursday, February 11, 2016 T...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q4 2015 Earnings Conference Call

02/09/16 at 8:30 AM ET

View Event

Leerink Partners 5th Annual Global Healthcare Conference

02/11/16 at 8:30 AM

View Event




Close
Form content here please :)